Juan S H, Lee T S, Tseng K W, Liou J Y, Shyue S K, Wu K K, Chau L Y
Division of Cardiovascular Research, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
Circulation. 2001 Sep 25;104(13):1519-25. doi: 10.1161/hc3801.095663.
Increasing evidence supports the role of heme oxygenase-1 (HO-1) in cytoprotective response and iron homeostasis. The object of this study was to investigate whether adenovirus-mediated gene transfer of HO-1 in arteries reduces iron overload and inhibits lesion formation in apolipoprotein E (apoE)-deficient mice.
Infection of rat aortic smooth muscle cells with adenovirus carrying the human HO-1 gene (Adv-HO-1) resulted in a high-level expression of HO-1 protein, which effectively reduced the hemin-induced iron overload in these cells. Adenovirus-mediated gene transfer in arteries in vivo was achieved by direct injection of Adv-HO-1 into the left ventricles of anesthetized animals. Transgene was expressed in the endothelium and aortic lesion of apoE-deficient mice after they had received recombinant adenovirus for 1 week and gradually decayed during the next 5 weeks. When young apoE-deficient mice (14 weeks old) received Adv-HO-1 (2.5 x 10(9) pfu) for 6 weeks, lesions that developed in the aortic root or aortic arch were significantly smaller than those in control littermates receiving empty viral vector. Furthermore, the iron deposition as well as tissue iron content was much less in aortic tissue of Adv-HO-1-treated mice. The inhibitory effect of HO-1 gene transfer on the progression of advanced lesions was also observed in older apoE-deficient mice (20 weeks old) receiving Adv-HO-1 intraventricularly.
Overexpression of HO-1 in vascular cells facilitates iron metabolism and attenuates development of atherosclerosis in apoE-deficient mice.
越来越多的证据支持血红素加氧酶-1(HO-1)在细胞保护反应和铁稳态中的作用。本研究的目的是调查动脉中腺病毒介导的HO-1基因转移是否能减少载脂蛋白E(apoE)缺陷小鼠的铁过载并抑制病变形成。
用携带人HO-1基因的腺病毒(Adv-HO-1)感染大鼠主动脉平滑肌细胞,导致HO-1蛋白高水平表达,有效降低了血红素诱导的这些细胞中的铁过载。通过将Adv-HO-1直接注射到麻醉动物的左心室,实现了体内动脉中腺病毒介导的基因转移。apoE缺陷小鼠在接受重组腺病毒1周后,转基因在内皮和主动脉病变中表达,并在接下来的5周内逐渐衰减。当年轻的apoE缺陷小鼠(14周龄)接受Adv-HO-1(2.5×10⁹ pfu)6周时,主动脉根部或主动脉弓中形成的病变明显小于接受空病毒载体的对照同窝小鼠。此外,Adv-HO-1处理小鼠的主动脉组织中铁沉积以及组织铁含量要少得多。在脑室注射Adv-HO-1的老年apoE缺陷小鼠(20周龄)中也观察到HO-1基因转移对晚期病变进展的抑制作用。
血管细胞中HO-1的过表达促进铁代谢,并减轻apoE缺陷小鼠动脉粥样硬化的发展。